Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
The center brings together hands on technology demonstrations, application expertise, and commercial operations
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
As Tracky launches integrated health solution
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Subscribe To Our Newsletter & Stay Updated
